Production of trypsin and chymotrypsin inhibitors by oral bacterial isolates.
Using an agar-skim milk gel method, over 300 oral bacterial isolates were tested for their ability to produce trypsin or chymotrypsin inhibitor. Eleven bacterial strains, including seven isolates identified as Bacteroides intermedius, were found to inhibit both proteolytic activities. The inhibitory factors of the 11 bacterial strains could be divided into two categories: i) heat-stable and dialysable, and ii) heat-labile and non-dialysable. The protease inhibitor activity of B. intermedius strains, which belongs to the latter category, was found in a membrane fraction as well as in a membrane-free extract. Furthermore, three strains of B. intermedius showed this inhibitory activity in the culture supernatant. In combination with plasma-derived protease inhibitors, the production of these additional protease inhibitors by oral bacteria could protect the host from tissue degradation.
Grenier
D
D
Département de Santé Buccale, Faculté de Médecine Dentaire, Université de Montréal, Québec, Canada.
D000328:Adult; D001421:Bacteria, Anaerobic / Q000378:metabolism*; D001426:Bacterial Proteins / Q000037:antagonists & inhibitors; D001439:Bacteroides / Q000378:metabolism; D002474:Cell-Free System; D002918:Chymotrypsin / Q000037:antagonists & inhibitors; D003773:Dental Plaque / Q000382:microbiology; D005051:Eubacterium / Q000378:metabolism; D005260:Female; D005673:Fusobacterium / Q000378:metabolism; D006090:Gram-Negative Bacteria / Q000378:metabolism*; D006801:Humans; D008297:Male; D010519:Periodontium / Q000382:microbiology*; D011480:Protease Inhibitors / Q000302:isolation & purification* / Q000378:metabolism*; D014361:Trypsin Inhibitors / Q000096:biosynthesis / Q000302:isolation & purification
D001426:Bacterial Proteins; D011480:Protease Inhibitors; D014361:Trypsin Inhibitors; D002918:Chymotrypsin